What is new in Phoenix 8.5?
了解 Phoenix 8.5 版本的最新进展和增强功能。Watch the webinar to learn…
Certara2024 年 2 月 26 日
Streamlining Your NCA Workflow
准备递交的 PK 分析面临着许多数据和合规方面的挑战。To work efficiently,…
Certara2024 年 1 月 18 日
Compliance in the Cloud: What you need to know about computer system validation when moving your application to the cloud
Learn key insights on computer system validation and compliance when moving applications to the cloud.…
Certara2023 年 10 月 27 日
How A Biotech Startup Company Increased Flexibility and Efficiency by Switching to Phoenix Cloud
Discover how a biotech startup enhanced flexibility and efficiency by adopting Phoenix Hosted, streamlining workflows…
Certara2023 年 9 月 8 日
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program
Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…
Certara2023 年 6 月 1 日
Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China
By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…
Certara2020 年 8 月 7 日
Conventional & Mechanistic IVIVC: Complementary or Clashing Methods?
An IVIVC (in vitro-in vivo correlation) is a mathematical relationship that predicts key pharmacokinetic parameters…
Certara2016 年 2 月 9 日
Common Misconceptions About Computer System Validation
2015 年 1 月 28 日 Drug development professionals frequently use computer systems to help them understand the…
Certara2015 年 1 月 28 日
Using Modeling and Simulation to Quantify the PK of an Anti-HIV Drug for Babies
As a scientist at Certara and proud Dad to my three kids, pediatric drug development…
Certara2015 年 1 月 15 日
